Clinical Trial Update: Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of empagliflozin for neutropenia in glycogen storage disease Type I (GSD I) due to G6PC deficiency and rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose 6 Phosphatase Deficiency
• Glycogen Storage Disease Type

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Glycogen Storage Disease Type I, Glucose 6 Phosphatase Deficiency | Phase 2 | Status: UNKNOWN